ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
61 hedge funds and large institutions have $8.79M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 18 closing their positions.
Holders
61
Holders Change
-14
Holders Change %
-18.67%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
12
Reduced
19
Closed
18
Calls
$65K
Puts
–
Net Calls
+$65K
Net Calls Change
+$88K
Top Buyers
Top Sellers
1 |
1
Citadel Advisors
Miami,
Florida
|
$0 |
2 |
2
Millennium Management
New York
|
$522K |
3 |
3
Morgan Stanley
New York
|
$62K |
4 |
4
Goldman Sachs
New York
|
$12K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$15K |